Dr. Dino T. Deconcini, MD

Dr. Deconcini practices at Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services.

Dr. Deconcini's NPI, 1689666307, was assigned on August 18, 2005. Dr. Deconcini graduated from Vagelos College of Physicians and Surgeons in 1992. Dr. Deconcini holds California license G84439.

Dr. Deconcini's primary practice is Providence Saint John's Health Center, at 2121 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5511.

Dr. Deconcini's primary practice is Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services. Dr. Deconcini is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Comprehensive Urology. Dmand AI also links Dr. Deconcini to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deconcini practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Deconcini's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Deconcini is board certified in urology by the American Board of Urology. Dmand AI has Dr. Deconcini's licenses on file in 2 states: California and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Deconcini treats.

CMS data shows 17,078 Medicare services from Dr. Deconcini across 48 procedure codes in 2024, for 945 Medicare patients. Medicare paid $555,857 for them.

CMS counts 945 Medicare patients who saw Dr. Deconcini in 2024. The largest group is 75 to 84, with 397 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deconcini's median patient age at 64, with 12% women.

In 2024, Dr. Deconcini wrote 1,947 Medicare Part D claims for 468 patients. 89% of them were for generic drugs. CMS names the drug for 1,826 of them, across 33 drugs with 11 or more claims each, at $218,261 in total drug cost. In 2023, CMS named 1,777 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Deconcini for performance year 2024, reported individually. Dr. Deconcini accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Deconcini. The most frequent topics are Prostatic Neoplasms. Dr. Deconcini has published most often in J Urol. Dr. Deconcini's most frequent co-authors are Timothy Bolton Boone, MD, PhD and Thomas Michael Wheeler, MD.

CMS Open Payments shows 642 general payments to Dr. Deconcini from 75 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Astellas Pharma US Inc paid the most, $1,881.

Dmand AI lists 1 award for Dr. Deconcini, most recently CMS Stage 1 2012 in 2011.

Dr. Deconcini graduated from Vagelos College of Physicians and Surgeons in 1992.

Dr. Deconcini is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.